256 related articles for article (PubMed ID: 16791749)
1. Near-infrared fluorescence imaging of tumor integrin alpha v beta 3 expression with Cy7-labeled RGD multimers.
Wu Y; Cai W; Chen X
Mol Imaging Biol; 2006; 8(4):226-36. PubMed ID: 16791749
[TBL] [Abstract][Full Text] [Related]
2. Fast clearing RGD-based near-infrared fluorescent probes for in vivo tumor diagnosis.
Cao J; Wan S; Tian J; Li S; Deng D; Qian Z; Gu Y
Contrast Media Mol Imaging; 2012; 7(4):390-402. PubMed ID: 22649045
[TBL] [Abstract][Full Text] [Related]
3. Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice.
Cheng Z; Wu Y; Xiong Z; Gambhir SS; Chen X
Bioconjug Chem; 2005; 16(6):1433-41. PubMed ID: 16287239
[TBL] [Abstract][Full Text] [Related]
4. (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.
Li ZB; Cai W; Cao Q; Chen K; Wu Z; He L; Chen X
J Nucl Med; 2007 Jul; 48(7):1162-71. PubMed ID: 17574975
[TBL] [Abstract][Full Text] [Related]
5. Optical imaging of integrin alphavbeta3 expression with near-infrared fluorescent RGD dimer with tetra(ethylene glycol) linkers.
Liu Z; Liu S; Niu G; Wang F; Liu S; Chen X
Mol Imaging; 2010 Feb; 9(1):21-9. PubMed ID: 20128995
[TBL] [Abstract][Full Text] [Related]
6. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
7. In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in an orthotopic glioblastoma model.
Hsu AR; Hou LC; Veeravagu A; Greve JM; Vogel H; Tse V; Chen X
Mol Imaging Biol; 2006; 8(6):315-23. PubMed ID: 17053862
[TBL] [Abstract][Full Text] [Related]
8. Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature.
Cai W; Chen K; Li ZB; Gambhir SS; Chen X
J Nucl Med; 2007 Nov; 48(11):1862-70. PubMed ID: 17942800
[TBL] [Abstract][Full Text] [Related]
9. In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts.
Chen X; Conti PS; Moats RA
Cancer Res; 2004 Nov; 64(21):8009-14. PubMed ID: 15520209
[TBL] [Abstract][Full Text] [Related]
10. A new optical imaging probe targeting αVβ3 integrin in glioblastoma xenografts.
Lanzardo S; Conti L; Brioschi C; Bartolomeo MP; Arosio D; Belvisi L; Manzoni L; Maiocchi A; Maisano F; Forni G
Contrast Media Mol Imaging; 2011; 6(6):449-58. PubMed ID: 22144022
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors.
Ye Y; Bloch S; Xu B; Achilefu S
J Med Chem; 2006 Apr; 49(7):2268-75. PubMed ID: 16570923
[TBL] [Abstract][Full Text] [Related]
12. RGD-human serum albumin conjugates as efficient tumor targeting probes.
Chen K; Xie J; Chen X
Mol Imaging; 2009; 8(2):65-73. PubMed ID: 19397852
[TBL] [Abstract][Full Text] [Related]
13. Spectroscopically well-characterized RGD optical probe as a prerequisite for lifetime-gated tumor imaging.
Mathejczyk JE; Pauli J; Dullin C; Napp J; Tietze LF; Kessler H; Resch-Genger U; Alves F
Mol Imaging; 2011 Dec; 10(6):469-80. PubMed ID: 22201538
[TBL] [Abstract][Full Text] [Related]
14. Tumor uptake of the RGD dimeric probe (99m)Tc-G3-2P4-RGD2 is correlated with integrin αvβ3 expressed on both tumor cells and neovasculature.
Liu Z; Jia B; Shi J; Jin X; Zhao H; Li F; Liu S; Wang F
Bioconjug Chem; 2010 Mar; 21(3):548-55. PubMed ID: 20184307
[TBL] [Abstract][Full Text] [Related]
15. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
Wu Y; Zhang X; Xiong Z; Cheng Z; Fisher DR; Liu S; Gambhir SS; Chen X
J Nucl Med; 2005 Oct; 46(10):1707-18. PubMed ID: 16204722
[TBL] [Abstract][Full Text] [Related]
16. microPET of tumor integrin alphavbeta3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4).
Wu Z; Li ZB; Chen K; Cai W; He L; Chin FT; Li F; Chen X
J Nucl Med; 2007 Sep; 48(9):1536-44. PubMed ID: 17704249
[TBL] [Abstract][Full Text] [Related]
17. Ligands for mapping alphavbeta3-integrin expression in vivo.
Schottelius M; Laufer B; Kessler H; Wester HJ
Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579
[TBL] [Abstract][Full Text] [Related]
18. Near-infrared fluorescent divalent RGD ligand for integrin αvβ₃-targeted optical imaging.
Ye Y; Akers W; Xu B; Bloch S; Odonkor C; Achilefu S
Bioorg Med Chem Lett; 2012 Sep; 22(17):5405-9. PubMed ID: 22871580
[TBL] [Abstract][Full Text] [Related]
19. Multimodal imaging of integrin receptor-positive tumors by bioluminescence, fluorescence, gamma scintigraphy, and single-photon emission computed tomography using a cyclic RGD peptide labeled with a near-infrared fluorescent dye and a radionuclide.
Edwards WB; Akers WJ; Ye Y; Cheney PP; Bloch S; Xu B; Laforest R; Achilefu S
Mol Imaging; 2009; 8(2):101-10. PubMed ID: 19397855
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
